Even though the liver is considered the primary organ of detoxification, the integrity of the intestinal epithelial barrier must not be underestimated. The gastrointestinal tract (GIT) is a major site for dealing with toxic burden. Over the course of a lifetime, the GIT processes more than 25 tonnes of food, which represents the largest load of antigens and toxins confronting the human body.
With the benefit of over two decades of experience to look back on, Dr Mark Donohoe takes us through the changing face of detoxification.
Greg Mapp is one of the founders of Mirikai, the revolutionary drug detoxification facility situated on the Gold Coast. The centre is now government funded and has grown into one of the largest of such centres in Australia.
In part one of the two part series Greg takes us through the history of the clinic and how medical care of illicit drug detox commonly involves integrative therapies and judicial supplementation to manage symptoms experienced by patients.
As a naturopath, nutritionist and herbalist with 13 years experience, Amie takes us through some core Naturopathic Principles that form the vital components of a successful, and wholistic gut repair program.
Not too long ago, beneficial bacteria was only thought about in relation to the gastrointestinal ecology. However in recent years we have discovered that the body plays host to a myriad of distinct bacterial colonies that play a vital role in health and disease.
In this episode Andrew and Dr Mark Donohoe discuss the microbiome beyond the gut with a focus on the reproductive system. As well as offering up some diet and lifestyle interventions that we as hosts can use to ensure the health of our resident bugs.
A recent review on intestinal microbiota and probiotics in coeliac disease (CD) revealed that research into CD and the effect of gluten on the intestinal-immune health in adults has only been studied since 2012; prior to that children were the cohort subjects.
Probiotics modulate the immune response in children suffering from coeliac disease by reducing the pro- inflammatory cytokines according to a recent double-blind, placebo-controlled trial.
Dr Mark Donohoe discusses the importance of gastrointestinal microbiome biodiversity for optimal health and wellbeing outcomes in our patients.